Trustees Of Columbia University In The City Of New York Vor Biopharma Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $46.9 Million
- Q4 2023
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 91,910 shares of VOR stock, worth $116,725. This represents 0.44% of its overall portfolio holdings.
Number of Shares
91,910
Previous 91,910
-0.0%
Holding current value
$116,725
Previous $194,000
6.19%
% of portfolio
0.44%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding VOR
# of Institutions
57Shares Held
41.2MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA22.7MShares$28.9 Million0.22% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$8.08 Million1.77% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT2.47MShares$3.13 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.48 Million0.0% of portfolio
-
Cowen And Company, LLC1.22MShares$1.55 Million0.02% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $48.3M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...